HEADER HYDROLASE 29-FEB-08 3CEN
TITLE FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(2-(((5-CHLORO-2-PYRIDINYL)
TITLE 2 AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: COAGULATION FACTOR X, HEAVY CHAIN;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: ACTIVATED FACTOR XA HEAVY CHAIN, UNP RESIDUES 235-468;
COMPND 5 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR;
COMPND 6 EC: 3.4.21.6;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: COAGULATION FACTOR X, LIGHT CHAIN;
COMPND 9 CHAIN: L;
COMPND 10 FRAGMENT: UNP RESIDUES 127-178;
COMPND 11 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR;
COMPND 12 EC: 3.4.21.6
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 OTHER_DETAILS: PROTEOLYTIC CLEAVAGE PRODUCT;
SOURCE 5 MOL_ID: 2;
SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 7 ORGANISM_COMMON: HUMAN;
SOURCE 8 OTHER_DETAILS: PROTEOLYTIC CLEAVAGE PRODUCT
KEYWDS GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION
KEYWDS 2 FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, CLEAVAGE ON PAIR
KEYWDS 3 OF BASIC RESIDUES, EGF-LIKE DOMAIN, GAMMA-CARBOXYGLUTAMIC ACID,
KEYWDS 4 HYDROXYLATION, POLYMORPHISM, ZYMOGEN
EXPDTA X-RAY DIFFRACTION
AUTHOR C.-H.CHANG
REVDAT 3 30-OCT-24 3CEN 1 REMARK
REVDAT 2 24-FEB-09 3CEN 1 VERSN
REVDAT 1 20-MAY-08 3CEN 0
JRNL AUTH J.R.CORTE,T.FANG,D.J.P.PINTO,W.HAN,Z.HU,X.-J.JIANG,Y.-L.LI,
JRNL AUTH 2 J.F.GAUUAN,M.HADDEN,D.ORTON,A.R.RENDINA,J.M.LUETTGEN,
JRNL AUTH 3 P.C.WONG,K.HE,P.MORIN,C.-H.CHANG,D.L.CHENEY,R.M.KNABB,
JRNL AUTH 4 R.R.WEXLER,P.Y.S.LAM
JRNL TITL STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTHRANILAMIDE-BASED
JRNL TITL 2 FACTOR XA INHIBITORS CONTAINING PIPERIDINONE AND PYRIDINONE
JRNL TITL 3 P4 MOIETIES
JRNL REF BIOORG.MED.CHEM.LETT. V. 18 2845 2008
JRNL REFN ISSN 0960-894X
JRNL PMID 18424044
JRNL DOI 10.1016/J.BMCL.2008.03.092
REMARK 2
REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.70
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1147871.750
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 61.9
REMARK 3 NUMBER OF REFLECTIONS : 26669
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.251
REMARK 3 R VALUE (WORKING SET) : 0.249
REMARK 3 FREE R VALUE : 0.294
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.900
REMARK 3 FREE R VALUE TEST SET COUNT : 1563
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2520
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2500
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.295
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.900
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1646
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0070
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 28003
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 8
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.67
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 11.40
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 584
REMARK 3 BIN R VALUE (WORKING SET) : 0.3720
REMARK 3 BIN FREE R VALUE : 0.4280
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 31
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.077
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2238
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 33
REMARK 3 SOLVENT ATOMS : 279
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 23.80
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.10
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.70000
REMARK 3 B22 (A**2) : -4.02000
REMARK 3 B33 (A**2) : 4.72000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26
REMARK 3 ESD FROM SIGMAA (A) : 0.17
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.370 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.240 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.000 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.810 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.30
REMARK 3 BSOL : 29.98
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : FXA.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : FXA.TOP
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3CEN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-08.
REMARK 100 THE DEPOSITION ID IS D_1000046682.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 27-OCT-03
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : MICROMAX CONFOCAL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO)
REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK)
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28031
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 64.2
REMARK 200 DATA REDUNDANCY : 4.300
REMARK 200 R MERGE (I) : 0.03500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 42.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66
REMARK 200 COMPLETENESS FOR SHELL (%) : 11.3
REMARK 200 DATA REDUNDANCY IN SHELL : 1.50
REMARK 200 R MERGE FOR SHELL (I) : 0.43600
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 51.51
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM SODIUM ACETATE, PH 5.5, 18%
REMARK 280 PEG6000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.45000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.40000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.25000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.40000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.45000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.25000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2720 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13430 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.6 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 LYS A 62 CG CD CE NZ
REMARK 480 ARG A 150 CG CD NE CZ NH1 NH2
REMARK 480 LYS A 223 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 61A 136.32 -173.58
REMARK 500 ARG A 115 -167.21 -171.48
REMARK 500 LEU L 88 -115.22 42.32
REMARK 500 GLN L 98 -111.21 -129.24
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 HOH 302-580 CORRESPOND TO AUTHORS ORIGINAL HOH 2-280
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FXA A 1
DBREF 3CEN A 16 244 UNP P00742 FA10_HUMAN 235 468
DBREF 3CEN L 87 138 UNP P00742 FA10_HUMAN 127 178
SEQRES 1 A 234 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO
SEQRES 2 A 234 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE
SEQRES 3 A 234 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR
SEQRES 4 A 234 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL
SEQRES 5 A 234 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY
SEQRES 6 A 234 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN
SEQRES 7 A 234 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL
SEQRES 8 A 234 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL
SEQRES 9 A 234 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER
SEQRES 10 A 234 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE
SEQRES 11 A 234 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU
SEQRES 12 A 234 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS
SEQRES 13 A 234 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE
SEQRES 14 A 234 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN
SEQRES 15 A 234 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP
SEQRES 16 A 234 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY
SEQRES 17 A 234 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL
SEQRES 18 A 234 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR
SEQRES 1 L 52 LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP GLN PHE
SEQRES 2 L 52 CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS ALA
SEQRES 3 L 52 ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS ILE
SEQRES 4 L 52 PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU GLU
HET FXA A 1 33
HETNAM FXA N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-
HETNAM 2 FXA (2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
HETSYN FXA N-{2-[(5-CHLOROPYRIDIN-2-YL)SULFAMOYL]PHENYL}-4-(2-
HETSYN 2 FXA OXOPYRIDIN-1(2H)-YL)BENZAMIDE
FORMUL 3 FXA C23 H17 CL N4 O4 S
FORMUL 4 HOH *279(H2 O)
HELIX 1 1 ALA A 55 GLN A 61 5 7
HELIX 2 2 GLU A 124A LEU A 131A 1 9
HELIX 3 3 ASP A 164 SER A 172 1 9
HELIX 4 4 PHE A 234 MET A 242 1 9
HELIX 5 5 LYS L 87 CYS L 96 5 10
SHEET 1 A 7 GLN A 20 GLU A 21 0
SHEET 2 A 7 LYS A 156 PRO A 161 -1 O MET A 157 N GLN A 20
SHEET 3 A 7 THR A 135 GLY A 140 -1 N VAL A 138 O LEU A 158
SHEET 4 A 7 PRO A 198 PHE A 203 -1 O VAL A 200 N ILE A 137
SHEET 5 A 7 THR A 206 TRP A 215 -1 O THR A 210 N HIS A 199
SHEET 6 A 7 GLY A 226 LYS A 230 -1 O ILE A 227 N TRP A 215
SHEET 7 A 7 MET A 180 ALA A 183 -1 N PHE A 181 O TYR A 228
SHEET 1 B 7 GLN A 30 ILE A 34 0
SHEET 2 B 7 GLY A 40 ILE A 46 -1 O GLY A 44 N ALA A 31
SHEET 3 B 7 TYR A 51 THR A 54 -1 O LEU A 53 N THR A 45
SHEET 4 B 7 ALA A 104 LEU A 108 -1 O LEU A 106 N ILE A 52
SHEET 5 B 7 ALA A 81 LYS A 90 -1 N ILE A 89 O VAL A 105
SHEET 6 B 7 LYS A 65 VAL A 68 -1 N VAL A 66 O HIS A 83
SHEET 7 B 7 GLN A 30 ILE A 34 -1 N LEU A 32 O ARG A 67
SHEET 1 C 2 PHE L 99 GLU L 102 0
SHEET 2 C 2 VAL L 107 SER L 110 -1 O VAL L 108 N HIS L 101
SHEET 1 D 2 TYR L 115 LEU L 117 0
SHEET 2 D 2 CYS L 124 PRO L 126 -1 O ILE L 125 N THR L 116
SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.48
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.63
SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.45
SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.63
SSBOND 5 CYS L 89 CYS L 100 1555 1555 2.54
SSBOND 6 CYS L 96 CYS L 109 1555 1555 2.47
SSBOND 7 CYS L 111 CYS L 124 1555 1555 2.46
SITE 1 AC1 13 GLU A 97 THR A 98 TYR A 99 ASP A 189
SITE 2 AC1 13 ALA A 190 CYS A 191 GLN A 192 TRP A 215
SITE 3 AC1 13 GLY A 216 GLY A 218 CYS A 220 GLY A 226
SITE 4 AC1 13 ILE A 227
CRYST1 56.900 72.500 78.800 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017575 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013793 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012690 0.00000